Bright Minds Biosciences Inc. - common stock

Bright Minds Biosciences Inc. - common stock Share · CA10919W4056 · DRUG (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Bright Minds Biosciences Inc. - common stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
3
0
0
0
No Price
01.05.2026 20:00
Current Prices from Bright Minds Biosciences Inc. - common stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
DRUG
USD
01.05.2026 20:00
86,96 USD
-0,99 USD
-1,13 %
IEXG: IEX
IEX
DRUG
USD
01.05.2026 19:59
86,87 USD
-1,09 USD
-1,23 %
XCNQ: CSE LISTED
CSE LISTED
DRUG.CN
CAD
01.05.2026 19:35
118,81 CAD
-1,07 CAD
-0,89 %
Share Float & Liquidity
Free Float 62,42 %
Shares Float 4,84 M
Shares Outstanding 7,76 M
Company Profile for Bright Minds Biosciences Inc. - common stock Share
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

Company Data

Name Bright Minds Biosciences Inc. - common stock
Company Bright Minds Biosciences Inc.
Symbol DRUG
Website https://brightmindsbio.com
Primary Exchange XNAS NASDAQ
ISIN CA10919W4056
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Ian McDonald
Market Capitalization 922 Mio
Country Canada
Currency USD
Employees -
Address 1500 – 1055 West Georgia Street, V6E 4N7 New York City
IPO Date 2021-02-09

Stock Splits

Date Split
14.07.2023 1:5

Ticker Symbols

Name Symbol
CSE LISTED DRUG.CN
NASDAQ DRUG
More Shares
Investors who hold Bright Minds Biosciences Inc. - common stock also have the following shares in their portfolio:
UNISECTOR: BIOPHARMA A
UNISECTOR: BIOPHARMA A Fund
WELL SA EO-,20
WELL SA EO-,20 Share